Qin et al. showed that G protein-coupled receptors (GPCRs) are closely related to the occurrence and metastasis of human tumors and that GPR18 GPCRs may be considered potential novel anticancer targets in metastatic melanoma (Qin et al., 2011). The gene discussed is GPR18; the disease is metastatic melanoma.